Scientific Articles
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
source: Journal of the American College of Cardiology
year: 2015
authors: Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G
summary/abstract:Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant inheritance) and a wild-type form (with predominant cardiac involvement). This article guides clinicians as to when the disease should be suspected, describes the appropriate diagnostic evaluation for those with known or suspected amyloidosis, and reviews the interventions currently available for affected patients.
organization: Mayo Clinic, USA; Indiana University School of Medicine, USA; Mayo Clinic, USA; Hospital de Santo Antonio, Portugal; Federal University of Rio de Janeiro of Brazil, Brazil; Boston University School of Medicine, USA; University Hospital Henri Mondor, France; Universitätsklinikum Münster, Germany; University of Pavia, ItalyDOI: 10.1016/j.jacc.2015.09.075
read more full text source
rareRelated
- An Overview of AL Amyloidosishttps://www.youtube.com/watch?v=uL580eHf...
- Hereditary Transthyretin AmyloidosisClinical characteristics. Hereditary tr...
- Amyloidosis: A Unifying Diagnosis for Nephrotic Syndrome and Congestive Cardiac FailureDiagnosing patients simply with heart fa...
- Pitfalls in Conducting Prospective Trials in Stage III Cardiac Amyloidosis – Experience from the REVEAL StudyVery few prospective clinical trials hav...
- hATTR Compass Genetic Testing and Counseling ProgramAkcea Therapeutics and Ambry Genetics ar...
- Hereditary Fibrinogen Aα-Chain AmyloidosisAmyloidosis is a rare disease caused by ...
- Cardiac Amyloidosis: An Update on Diagnosis and TreatmentCardiac amyloidosis (CA), once thought t...
